Is an FDA warning letter a reason to avoid a company?

No. A warning letter is FDA objecting to what a company wrote, not to what it sells, and not one of the 47 letters carried by companies on this roster states any action that stopped a business trading. It is worth reading. It is not a verdict.

How many companies here have one?

47 of the 412 companies in this roster carry one, and 47 of those have a published review here.

What does a warning letter actually allege?

Two things, and both are about language. The first is a label: FDA says that where a compounded product is pictured with the telehealth company's own name on it, that name implies the company compounded the drug, and in every one of these cases it did not; a pharmacy did. The second is a claim: sentences like Same active ingredient in Ozempic and Wegovy or FDA-approved meds., which FDA says imply an approval compounded products have never had.

FDA states the underlying position the same way in every letter: Compounded drug products are not FDA-approved. If you take away one sentence, take that one. It is not a criticism of any company; it is the legal category the product sits in, and it is true of every compounded GLP-1 on this site whether or not the seller has a letter.

Has any of these letters stopped a company trading?

No. As of September 2, 2026, not one of the 47 states an executed seizure, injunction, recall or shutdown. Every one carries the same forward-looking sentence about what may follow if the company does not respond within fifteen days. That sentence is a warning about a possible future, and reading it as a record of something that already happened is the single most common way these letters get misreported.

Why do so many of them share a date?

Because they are sweeps. 11 are dated June 8, 2026, 18 are dated February 20, 2026, and 16 are dated September 9, 2025. A company that received one on a sweep date was not singled out; it was one of a batch FDA reviewed in the same pass, and the review dates in the letters say so: they cluster in the months before each issue date.

That is worth knowing when you compare two companies. The absence of a letter can mean a company writes carefully. It can also mean nobody has looked at it yet.

How do you know the letter is about this company?

Because none of them was matched on the brand name. 0 of the 47 letters name, in their own text, the exact website this roster reads its prices from. That is the strongest match available, and it leaves nothing to interpret. The other 47, altRx, Eden, Fitish, Harper Meds, Joi + Blokes, Maximus, Mint Med, NativeMed, NexLife, OrderlyMeds, Roen Rx, Alan Health, Belle Health, Bliv, Fifty 410, FitRx, Genesis Health, GoodGirlRx, Ivím Health, Kin Meds, MaxLife, Measured, MEDVi, NewSelf, Premium Health, Refills, SkinnyRx, Strut Health, WeightCare, Bioverse, Curex, Direct Meds, Elevated Health, Healthon, Hers, Hims, Intimate Rose, Lovely Meds, LumiMeds, MyStart Health, Nova MD, Remedy Meds, Sprout Health, Tuyo Health, Zealthy, Walgreens Weight Management, and Walgreens Weight Management, were matched on the legal entity plus the street address printed on the company's own pages, because the letter reviews a different top-level domain for the same business. Each review says which of the two happened.

How does this site handle a company with a letter?

Exactly as it handles a company without one. The letter goes in the review, numbered, dated, with FDA's own words for the allegation and a note that no action halted the business. Nothing in the code that builds a board, chooses a comparison or places a link reads whether a letter exists: every list on this site orders by what a month costs, and the roster's own file carries the rule at the top of it.

5 of the 47 companies here with a letter pay us a commission, and each kept its place on every board it was already on.

What this doesn't claim

• This is a count of the index, not of the market47 of 412 companies in this roster. The roster is not every company selling a GLP-1 in the United States and does not claim to be.
• Absence proves only that none turned up365 companies here returned no letter under their name or domain on September 2, 2026. A letter filed under an unnamed parent company would not show up in that search.
• A letter is a moment, and companies respond to themEach of these letters demanded a written response within fifteen days. FDA's index does not record whether a company made the changes. Several of the claims FDA quotes were no longer live on the companies' pages as of their reviews.

What else do people ask about GLP-1 warning letters?

• Does an FDA warning letter mean a GLP-1 company is unsafe?No, and none of the 47 letters recorded here says anything of the kind. Every one of them is about labeling and marketing: what a product's pictured label implies about who compounded it, and whether a sentence on a web page implies an FDA approval a compounded product does not have. A letter is FDA telling a company to fix its words. It is not a finding about the medicine and it is not a license being pulled.
• Can a company keep selling after a warning letter?All 47 of these companies were still selling as of their reviews. Not one of the letters states an action that halted a business: no seizure, no injunction, no recall. Each carries the same forward-looking sentence about what could happen if the company does not respond, which is a warning about the future rather than a record of the past.
• How many GLP-1 telehealth companies have an FDA warning letter?47 of the 412 companies in this roster do, and 47 of those have a published review here. Every company in the roster was screened by company name and by domain against FDA's full warning-letter index of 3,677 letters, as of September 4, 2026. That is a count of what the index holds for these companies, not a count of the market.
• Does this site rank a company lower for having a warning letter?No. Nothing in the code that builds a board, a link or a placement reads whether a letter exists. The ordering rule on every list is price, and the roster's own file says at the top that no field may gate a listing on a letter. A letter appears in the review, dated and numbered, with what it alleges. What a reader does with it is the reader's decision.

What FDA quoted, company by company

One row per published review, with the sentence FDA lifted out of that company's own site. These are FDA's transcriptions of the companies' marketing, not our summaries of FDA's objection.

Every letter is on FDA's own website under its number. The full text of each allegation, the recipient address it was sent to, and the domain FDA says it reviewed are on each company's review under On the record. 412 reviews are published here; 47 of them carry a letter.

Some companies named here pay us a commission when a reader starts care through a marked link. The one marked link on this page is one of them, picked by rule and disclosed beside it. Nothing above is ordered by who pays: the letters are listed newest first and the claim table follows the roster's own order. Who pays us · how we review · every review.